Lawmakers probe pharmacy ties to drug shortages

Rep. Elijah Cummings (D-MD) questions witnesses during the House Oversight and Government Reform Committee hearing on ''Credit Rating Agencies and the Financial Crisis,'' on Capitol Hill in Washington October 22, 2008.

Credit: Reuters/Mitch Dumke

By Anna Yukhananov

WASHINGTON | Wed Mar 21, 2012 5:16pm EDT

WASHINGTON (Reuters) - Lawmakers are investigating three shadowy pharmacies in Maryland and North Carolina for diverting critical but scarce drugs from patients to wholesalers, who are then able to resell the medicine at sometimes big markups.

Elijah Cummings, the senior Democrat on the House Committee on Oversight and Government Reform, began a probe in October to discover why certain companies were selling cancer drugs at more than a hundred times their normal cost.

Shortages of hundreds of drugs including cisplatin, a highly effective treatment for testicular cancer, and fluorouracil for colon and other cancers have helped create a lucrative shadow market.

The Food and Drug Administration has said the number of drugs in short supply, which also include anesthesiology and nutrition medications, had risen to 220 in 2011 from 56 in 2006.

According to preliminary details of Cummings' investigation, made public on Wednesday, some wholesalers opened their own sham pharmacies to obtain drugs in short supply and re-sell them. One wholesaler increased the price tenfold from the pharmacy cost.

"It's shocking to the conscience that anyone because of their greed would deny medicines to patients, who are in many instances in critical condition," Cummings said in an interview.

Read this article:
Lawmakers probe pharmacy ties to drug shortages